Entrepreneurs gather for Cornell-hosted summit in NYC

More than 500 people attended Entrepreneurship at Cornell's Summit 2016 Nov. 4 in New York City where they heard about ways to improve company culture and strategies for recovering from a setback.

'Goldwater' explores former Roosevelt Island landmark

The "Goldwater: Autopsy of a Hospital" exhibition in Milstein Hall, features photography of the Roosevelt Island landmark that stood on the site of the Cornell Tech campus.

Cornell dedicates memorial to alumni lost on 9/11

A memorial in Anabel Taylor Hall, honoring the 21 Cornellians who were victims of the Sept. 11, 2001, terrorist attacks, was dedicated in a ceremony Oct. 28.

Admissions underway for first class on new Cornell Tech campus

In August 2017, Cornell Tech's inaugural Roosevelt Island class will move into a campus built for innovation and creative collisions. Cornell Tech is accepting applications in seven master’s programs.

Robert F. Smith School dedicated in inspiring ceremony

In recognition of a $50 million gift aimed at enriching the diversity of undergraduate engineering, the Robert Frederick Smith School of Chemical and Biomolecular Engineering was formally dedicated Oct. 21.

$2M gift to drive Weill Cornell advances in immunotherapy

To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.

Researchers, alums receive NIH New Innovator Awards

Two Cornell researchers and two alumni were among 48 scientists nationwide who received $1.5 million awards from the National Institutes of Health.

Research project to combat 'superbugs,' antibiotic resistance

Cornell researchers received a $500,000 grant from the Centers for Disease Control and Prevention to help in a national initiative to combat drug-resistant organisms, sometimes referred to as "superbugs."

Chemotherapy drives bladder cancer treatment resistance

New research by Weill Cornell Medicine shows chemotherapy kills the most common type of bladder cancer, urothelial cancer, but it also shapes genetic evolution of remaining urothelial cancer cells.